Table 1.

Plasma concentrations of triglycerides, cholesterol, creatinine, sodium, and potassium in vehicle-, lovastatin-, and bezafibrate-treated deoxycorticosterone acetate-salt micea

TreatmentTriglycerides (mg/dl)Cholesterol (mg/dl)Creatinine (mg/dl)Na (mmol/L)K (mmol/L)
aBezafibrate decreased plasma cholesterol significantly compared with vehicle or lovastatin mice.
bP < 0.05, bezafibrate versus vehicle/lovastatin.
Vehicle74.64 ± 6.41188.14 ± 11.560.45 ± 0.05153.29 ± 1.054.21 ± 0.20
Lovastatin78.29 ± 8.45182.86 ± 12.270.47 ± 0.06153.69 ± 1.834.23 ± 0.29
Bezafibrate60.63 ± 3.95128.50 ± 18.13b0.39 ± 0.03155.38 ± 2.174.78 ± 0.52